NYSE ARCA | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 5.08% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.67% |
| ONC | BeiGene, Ltd. | Healthcare | Biotechnology | 4.23% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.12% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.08% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 4.00% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.93% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.79% |
| BRKR | Bruker Corporation | Healthcare | Medical Devices | 3.77% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.69% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 3.65% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.59% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.58% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 3.55% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.51% |
| WAT | Waters Corporation | Healthcare | Diagnostics & Research | 3.42% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 3.41% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.37% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 3.35% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.33% |